Based on the profound scientific acknowledge and rich research experience, the metabolic disease pharmacological research system. developed by TriApex can provide various metabolic pharmacology research services for clients requiring new drug discovery, including providing scientific ideas and suggestions, participating in research protocol design, implementation of research protocols, analysis and interpretation of experimental data, and collaborative development of new disease models.
Obesity model: We have completed evaluation projects for over 50 candidate compounds.
Diabetes model: We have completed pharmacodynamics studies of various drugs, including Metformin, PPAR agonists, DPP4 inhibitors, GLP-1 agonists, FGF-21 and PCSK9s